ストックスクリーナーアプリを入手
75.09
0.23%
0.176
前日終値:
$74.91
開ける：
$74.93
24時間の取引高:
612.81K
Relative Volume:
0.23
時価総額：
$16.76B
収益：
$4.04B
当期純損益:
$557.10M
株価収益率:
31.15
EPS:
2.4102
ネットキャッシュフロー:
$916.70M
1週間 パフォーマンス:
+0.37%
1か月 パフォーマンス:
+0.29%
6か月 パフォーマンス:
+8.85%
1年 パフォーマンス:
+18.02%
1日の値動き範囲:
$74.93
$75.09
1週間の範囲:
$74.84
$75.26
52週間の値動き範囲:
$51.90
$75.36
Hologic Inc Stock (HOLX) Company Profile
Compare HOLX vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
75.08 | 16.72B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
493.65 | 169.97B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
177.64 | 50.58B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.41 | 38.58B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
45.06 | 37.11B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
252.46 | 35.80B | 5.40B | 1.49B | 1.78B | 10.12 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-12 | ダウングレード | Argus | Buy → Hold |
| 2026-01-05 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2025-11-21 | ダウングレード | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-08-18 | アップグレード | Argus | Hold → Buy |
| 2025-08-06 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | アップグレード | Citigroup | Neutral → Buy |
| 2025-05-27 | 繰り返されました | Needham | Hold |
| 2025-03-03 | ダウングレード | Argus | Buy → Hold |
| 2025-02-06 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | ダウングレード | Needham | Buy → Hold |
| 2024-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2024-12-10 | 開始されました | Jefferies | Hold |
| 2024-12-10 | 繰り返されました | Needham | Buy |
| 2024-10-01 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-06-27 | 開始されました | Stephens | Overweight |
| 2024-04-03 | アップグレード | Citigroup | Neutral → Buy |
| 2023-07-14 | アップグレード | Needham | Hold → Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-07-20 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-07-20 | 開始されました | UBS | Neutral |
| 2022-07-18 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2021-12-15 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-10-14 | 開始されました | Redburn | Neutral |
| 2021-07-06 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-11-20 | ダウングレード | Needham | Buy → Hold |
| 2020-11-05 | 繰り返されました | Needham | Buy |
| 2020-06-30 | アップグレード | Cowen | Market Perform → Outperform |
| 2020-06-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | 繰り返されました | Needham | Buy |
| 2020-04-30 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | 繰り返されました | Needham | Buy |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-09-26 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | 繰り返されました | Needham | Buy |
| 2019-05-02 | 繰り返されました | Needham | Buy |
| 2019-01-31 | 繰り返されました | Needham | Buy |
| 2019-01-02 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | 開始されました | UBS | Neutral |
| 2018-09-13 | ダウングレード | BofA/Merrill | Buy → Neutral |
すべてを表示
Hologic Inc (HOLX) 最新ニュース
Hologic, Inc. $HOLX Shares Sold by Wealthfront Advisers LLC - MarketBeat
Illinois Municipal Retirement Fund Purchases 29,143 Shares of Hologic, Inc. $HOLX - MarketBeat
Is Wall Street bullish or bearish on Hologic stock? - MSN
How The Narrative Surrounding Hologic (HOLX) Has Shifted With The US$79 All Cash Buyout - Yahoo Finance
Hologic, Inc. $HOLX is Sound Shore Management Inc CT's 9th Largest Position - MarketBeat
Hologic, Inc. $HOLX Shares Sold by Allianz Asset Management GmbH - MarketBeat
China regulator approves Blackstone, TPG acquisition of medtech firm Hologic - Reuters
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Is Wall Street Bullish or Bearish on Hologic Stock? - Barchart.com
Is Hologic (HOLX) Pricing Reflect Its Cash Flow Strength After Recent Stability In Diagnostics? - simplywall.st
Azzad Asset Management Inc. ADV Trims Position in Hologic, Inc. $HOLX - MarketBeat
Bone Mineral Densitometry (BMD) Market is expected to reach US$ - openPR.com
China approves Blackstone, TPG acquisition of medtech firm Hologic - The Economic Times
China market regulator: approved Blackstone and TPG's acquisition of medical technology company Hologic - marketscreener.com
Market Fear: Whats the profit margin of Hologic Inc2025 Technical Patterns & Smart Swing Trading Alerts - baoquankhu1.vn
Twin Capital Management Inc. Cuts Position in Hologic, Inc. $HOLX - MarketBeat
Nuance Investments LLC Sells 1,017,410 Shares of Hologic, Inc. $HOLX - MarketBeat
US Market Recap: Does Hologic Inc have a sustainable dividendJuly 2025 Opening Moves & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Hologic, Inc. $HOLX Holdings Cut by IQ EQ FUND MANAGEMENT IRELAND Ltd - MarketBeat
Hologic, Inc. (HOLX) Announces Shareholder Approval for Merger w - GuruFocus
Hologic Shareholders Approve Blackstone and TPG Buyout Deal - TipRanks
SA's Competition Commission approves proposed deal whereby Hopper parent intends to buy Hologic, without conditions - marketscreener.com
Hologic’s Aptima assay secures FDA approval for HPV primary screening - Medical Device Network
Machina Capital S.A.S. Buys 13,426 Shares of Hologic, Inc. $HOLX - MarketBeat
Hologic’s Aptima HPV assay receives FDA approval for primary screening By Investing.com - Investing.com Nigeria
Hologic Goes Global: Can International Expansion Offset China and Africa Headwinds? - Smartkarma
FDA Approves Hologic’s Aptima HPV Assay Primary Screening Option - Medical Product Outsourcing
Hologic receives FDA approval for Aptima® HPV assay primary screening option, expanding cervical health portfolio - marketscreener.com
Hologic Says US FDA Approves Aptima HPV Testing Assay - marketscreener.com
Hologic’s Aptima HPV assay receives FDA approval for primary screening - Investing.com
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health PortfolioHologic, Inc. - Hologic, Inc. - Investor Relations
Hologic Receives FDA Approval for Aptima HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio - Business Wire
Analysts Have Conflicting Sentiments on These Healthcare Companies: Hologic (HOLX) and Irhythm Technologies (IRTC) - The Globe and Mail
United States Bone Densitometer Devices Market is expected - openPR.com
National Pension Service Grows Position in Hologic, Inc. $HOLX - MarketBeat
New York State Common Retirement Fund Grows Stock Holdings in Hologic, Inc. $HOLX - MarketBeat
Robert Olstein's Strategic Moves: Exiting Hologic Inc with a -1.44% Impact - Yahoo Finance
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Hologic, Inc. (HOLX) is attracting investor attention: Here is what you should know - MSN
Hologic (HOLX) International Revenue Performance Explored - Yahoo Finance
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Hologic, Inc. (HOLX) Stock Analysis: Unpacking Growth Potential Amidst a Hold Rating Consensus - DirectorsTalk Interviews
Is Hologic Inc vulnerable to short sellersMarket Activity Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
(HOLX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Market Outlook: What are analysts price targets for Hologic Inc2025 Price Momentum & Weekly Top Performers Watchlists - baoquankhu1.vn
Hologic (HOLX) Q1 2026 Margin Compression Reinforces Cautious Community Narratives - Sahm
Evercore ISI Adjusts Hologic Price Target to $76 From $78, Maintains In Line Rating - marketscreener.com
Hologic Q1 comes up short of Street expectations ahead of sale to private equity - MassDevice
HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash - TradingView
Decoding Hologic Inc (HOLX): A Strategic SWOT Insight - GuruFocus
Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Hologic Inc (HOLX) 財務データ
収益
当期純利益
現金流量
EPS
2.05%
大文字化:
|
ボリューム (24 時間):